Article Abstract

Disease burden and productivity cost of chronic rhinosinusitis patients referred to a tertiary centre in Australia

Authors: Timothy Liu, Thomas Cooper, James Earnshaw, Anders Cervin


Background: This study aims to examine the productivity cost of chronic rhinosinusitis (CRS) in Australia. Secondary objective is to describe the use of Sino-Nasal Outcome Test-22 (SNOT-22) and its associated domains.
Methods: In a retrospective approach, data were collected on productivity loss and SNOT-22 among 309 patients referred for management of CRS at a tertiary rhinology clinic. Productivity cost was defined via the human capital approach and monetised from the average weekly income recorded by the Australian Bureau of Statistics, May 2016.
Results: CRS-related productivity cost was determined to be 37.3 work days or Australian Dollars (AUD) $10,893.84 per patient per annum. Higher productivity cost significantly correlated to higher SNOT-22 scores (P value: 0.014) and younger working age (P value: 0.005). The mean SNOT-22 score was 42.0 with no specifically worse domains.
Conclusions: The estimated productivity cost of CRS provides insights and incentives for its cost-effective management.